
Velesila Pharmaceuticals Private Limited
About Velesila Pharmaceuticals Private Limited
Data last updated:
Velesila Pharmaceuticals Private Limited is a private limited company based in Bahadurgarh, Haryana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 17 April 2023.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U21002HR2023PTC110767.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sudhir Kumar Bhatta and Himanshu Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T5 – 0905, Jhajja – Bahadurgarh Rd Sector 37 Bahadurgarh, Haryana, India – 124507.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.14 Lakh, a growth of 101% compared to the previous year. For the same year it recorded a net profit of ₹92 (net margin 0%) and EBITDA of ₹751 (EBITDA margin 0%).
Company details
Contact details
Velesila Pharmaceuticals Private Limited's registered office is in Bahadurgarh, Haryana.
- Registered AddressT5 – 0905, Jhajja – Bahadurgarh Rd Sector 37 Bahadurgarh, Haryana, India – 124507
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Velesila Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Velesila Pharmaceuticals Private Limited, buy the company report.
Financials of Velesila Pharmaceuticals Private Limited
FY 2025 filings availableVelesila Pharmaceuticals Private Limited reported revenue of ₹26.14 Lakh (up 101% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 101% in the latest year. EBITDA rose 130% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹751 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹92 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0% | |
| Net Profit Margin | 0% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Velesila Pharmaceuticals Private Limited, buy the company report.
Board of directors of Velesila Pharmaceuticals Private Limited
Velesila Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Kumar Bhatta | Director | 17 Apr 2023 | 3 Years 6 Months | Current |
| Himanshu Mishra | Director | 17 Apr 2023 | 3 Years 6 Months | Current |
| Sunil Kumar Mishra | Director | 04 Feb 2025 | 1 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Velesila Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Velesila Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Velesila Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Velesila Pharmaceuticals Private Limited has 5 board changes on record since 2023: 4 appointments and 1 cessation. The latest: Anjana Bhatt ceased to be Director on 04 Feb 2025.
Frequently asked questions
Velesila Pharmaceuticals is an active private limited company based in Bahadurgarh, Haryana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 17 April 2023 (3+ years old) and is registered under CIN U21002HR2023PTC110767.
Velesila Pharmaceuticals has 3 current directors:
- Sudhir Kumar Bhatta - Director
- Himanshu Mishra - Director
- Sunil Kumar Mishra - Director
The latest financial statements of Velesila Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Velesila Pharmaceuticals is U21002HR2023PTC110767. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Velesila Pharmaceuticals was incorporated on 17 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Haryana.
Anjana Bhatt ceased to be Director on 04 Feb 2025. Sunil Kumar Mishra was appointed as Director on 04 Feb 2025. Anjana Bhatt was appointed as Director on 17 Apr 2023. Velesila Pharmaceuticals has 5 board changes on record in total.
The registered office of Velesila Pharmaceuticals is at T5 – 0905, Jhajja – Bahadurgarh Rd Sector 37 Bahadurgarh, Haryana, India – 124507.
Velesila Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Velesila Pharmaceuticals can be reached at its registered office: T5 – 0905, Jhajja – Bahadurgarh Rd Sector 37 Bahadurgarh, Haryana, India – 124507.
Velesila Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Haryana.

